NEW
YORK (Reuters) - The Dow ended at a record high on Friday, boosted
by IBM, while a rebound in high-growth momentum names helped the
broader market.

Consumer discretionary shares also lifted the market, with the stock
of Gap Inc <GPS.N> up 3.3 percent at $40.52 after the apparel
retailer reported upbeat April sales and gave a profit forecast that
surpassed Wall Street's expectations. The S&P consumer discretionary
index <.SPLRCD> was up 0.6 percent.

Apple Inc <AAPL.O> was the biggest drag on both the benchmark S&P
500 index and the Nasdaq 100 <.NDX> on news that it is close to
paying a record $3.2 billion for Beats Electronics, an expensive
foray into music streaming and headphone gear, two people with
knowledge of the matter said.

Some analysts questioned whether Beats, valued at $1 billion during
its last funding round in September, was worth that price. Apple
shares fell 0.4 percent to $585.54.

Momentum names advanced, with shares of Gilead Sciences Inc <GILD.O>
up 1.3 percent at $79.76. Netflix Inc <NFLX.O> shares rose 2.1
percent to $328.55 after the company increased the price of its most
popular video streaming plan by $1 a month.

The gains came after a volatile week for those shares. The S&P 500
has alternated between gains and losses each day this week, and the
Nasdaq has dropped for three straight sessions - its longest losing
streak since early April - as Internet-related stocks came under
pressure.

Trading was mostly lackluster, with about 5.7 billion shares
changing hands on the U.S. exchanges, below the 6.2 billion
month-to-date average, according to data from BATS Global Markets.

"The volatility and the decline in a lot of growth stuff is wearing
people out," said Michael James, managing director of equity trading
at Wedbush Securities in Los Angeles. "There's a lot of trader
fatigue."

Shares of International Business Machines Corp <IBM.N> rose 0.6
percent to $190.08 and helped lift the Dow to a record close.

For the week, the Dow rose 0.4 percent, while the S&P 500 dipped 0.1
percent and the Nasdaq fell 1.3 percent. This marked the Nasdaq's
biggest weekly percentage decline in a month.

The Russell 2000 <.TOY> gained 0.9 percent. Early in the session, it
flirted with correction territory, defined as a 10 percent drop from
a recent peak. At its session low, the Russell touched 1,091.50,
nearly 10 percent below its all-time closing high of 1,208.65
reached on March 4.

Healthcare stocks rose, with shares of Merck <MRK.N> up 0.7 percent
at $55.21 a day after U.S. health regulators approved a blood-clot
prevention drug developed by Merck for use by patients who have had
a heart attack or who suffer from blockages in the arteries of the
legs. The S&P healthcare index <.SPXHC> was up 0.6 percent.